PREPARATION, CHARACTERIZATION AND STUDIES OF PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES OF DRUGS COATING LACTOSE IN FLUIDIZED BEDS
Objective: Study physicochemical properties and activity of biotechnological drugs coating lactose particles in fluidized beds for the development of a prospective approach of their identification.
Methods: Lactose monohydrate as pharmaceutical excipient; affinity-purified polyclonal rabbit antibodies to recombinant human interferon-gamma as a drug substance; Pilotlab fluid bed apparatus was used for lactose powder saturation with solutions of pharmaceutical substances to the point of granulation (pelletizing); inverse light scattering method (2D-LS) for analysis of micron vibrations frequency spectra of samples surfaces for light intensity distribution in time by values of d1, d2, d3 primary descriptors; low angel and dynamic laser light scattering (LALLS, DLS) methods for distribution of lactose-water (LW) supramolecular complexes into volume fractions (micron "size spectra"), using the Master Sizer 2000 instrument and Zeta Sizer Nano ZS instrument in the nanoscale; Spirotox method for research of biological activity to determine the activation energy (Ea) values of cell death in solutions of tested samples.
Results: Changes in 2D-LS scattering time on sample surfaces, described by topological descriptors, made it possible to clearly differentiate the intact lactose from fluidized samples by specific corridors in coordinates di=F(t). The calculated activation energy (Ea) values of cell biosensor death process in solutions of drugs coating lactose allow to characterize the biological activity of it in the initial (by Ea increase) and activated state (by Ea decrease) after the creation of intra-laboratory transmucosal conditions. A unique dimensional spectrum of LW complexes in the nanoscale range was obtained by DLS. The differences between samples in the distribution of LW complexes in the size range from 1 µm to 125 µm was showed by LALLS.
Conclusion: The developed approach, including Сhemometrics, laser and biotesting methods can be used for qualitative the analysis tasks as well as for analytical control of the fluidization process in cases where identifiable pharmaceutical substances are not distinguishable by traditional analytical methods.
2. Mohs RC, Greig NH. Drug discovery and development: role of basic biological research. Alzheimers Dement (NY) 2017;3:651–7.
3. Durgapal S, Mukhopadhyay S, Goswami L. Preparation, characterization and evaluation of floating microparticles of ciprofloxacin. Int J Appl Pharm 2017;9:1-8.
4. Bock CP, I Cho Y. Hydrodynamic and heat transfer study of dispersed fluids with submicron metallic oxide particles. Ex Heat Transfer 1998;11:151-70.
5. Sikalo S, Delalic N, Ganic EN. On the two-phase dispersed flow hydrodynamics and heat transfer investigations. Renewable Technol Sustainable Dev 2002;1:667-81.
6. Ommen JR, Manuel JV, Pfeffer RL. Fluidization of nanopowders: a review. J Nanopart 2012;43:737-48.
7. Cvetkovski CG, Reitsma S, Bolisetti T, Ting S. Heat transfer in a U-bend pipe: dean number versus reynolds number. Sustain Energy Techn 2015;11:148-58.
8. Filatov N, Belousov K, Bukatin A, Kukhtevich I, Evstrapov A. The study of mixing of reagents within a droplet in various designs of microfluidic chip. J Phys: Conf Ser 2016;7:741-2.
9. Karimi A, Yazdi S, Ardekani AM. Hydrodynamic mechanisms of cell and particle trapping in microfuidics. Biomicrofuidics 2013;7:215-7.
10. Zhang S, Wang Y, Onck P, Toonder Jd. A concise review of microfluidic particle manipulation methods. Microfluid Nanofluid 2020;24:23-53.
11. Soleymani A, Kolehmainen E, Turunen I. Numerical and experimental investigations of liquid mixing in T-type micromixers. Chem Eng J 2008;135:S219-28.
12. Dey P, Saha SK, Chakraborty S. Confluence of channel dimensions and groove width dictates slippery hydrodynamics in grooved hydrophobic confinements. Microfluid Nanofluid 2020;24:232-46.
13. Monnard PA, Peter Walde. Current Ideas about prebiological compartmentalization. Life 2015;5:1239-13.
14. Epstein O. The spatial homeostasis hypothesis. Symmetry 2018;10:103-17.
15. Slastnikova TA, Ulasov AV, Rosenkranz AA, Sobolev AS. Targeted intracellular delivery of antibodies: the state of the art. Front Pharmacol 2018;24:9-12.
16. Chames P, Regenmortel MV, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 2009;157:220-33.
17. Almeida H, Amaral MH, Lobao P. Drugs obtained by biotechnology processing Brazilian. J Pharm Sci 2011;47:199-208.
18. Mkrtumyan A, Romantsova T, Vorobiev S, Volkova A, Vorokhobina N, Tarasov S, et al. Efficacy and safety of subetta add-on therapy in type 1 diabetes mellitus: the results of a multicenter, double-blind, placebo-controlled, randomized clinical trial. Diabetes Res Clin Pract 2018;142:1-9.
19. Smith JA, Judd J. Covid-19: vulnerability and the power of privilege in a pandemic. Health Promot J Austr 2020;20:1-3.
20. Odnovorov AI, Grebennikova TV, Pleteneva TV. Specific influenza therapy: current state and prospects (review). Razrab Regist Lek Sredstv 2020;9:83-91.
21. European Pharmacopoeia 7.0 V.1-2. Strasbourg: Council of Europe; 2010.
22. Zhang J, Wu CY, Pan X, Wu C. On identification of critical material attributes for compression behaviour of pharmaceutical diluent. Materials 2017;10:845?61.
23. Çarçabal P, Jockusch RA, Hünig I, Snoek LC, Kroemer RT, Davis BG, et al. Hydrogen bonding and cooperativity in isolated and hydrated sugars: mannose, galactose, glucose, and lactose. J Am Chem Soc 2005;127:11414-25.
24. Epshtein OI, Shtark MB, Kolyadko TM. US patent 8 535 664. Method of treating a pathological syndrome and a pharmaceutical agent. Inventors; 2013.
25. Don E, Farafonova O, Pokhil S, Barykina D, Nikiforova M, Shulga D, et al. Use of piezoelectric immunosensors for detection of interferon-gamma interaction with specific antibodies in the presence of released-active forms of antibodies to interferon-gamma. Sensors 2016;20:1-10.
26. Nasr A, Qushawy M, Swidan S. Spray dried lactose based proniosomes as stable provesicular drug delivery carriers: screening, formulation, and physicochemical characterization. Int J Appl Pharm 2018;10:125-37.
27. Wang J, Shao Y, Yan X, Zhu J. Review of (gas)-liquid-solid circulating fluidized beds as biochemical and environmental reactors. Chem Eng J 2019;12:19-21.
28. Loh ZH, Dawn ZL, Chan LW, Liew CV, Heng PS. Spray granulation for drug formulation. Expert Opin Drug Delivery 2011;8:1645-61.
29. Wang J, Shao Y, Yan X, Zhu J. Review of (gas)-liquid-solid circulating fluidized beds as biochemical and environmental reactors. Chem Eng J 2019;12:19-51.
30. Jawecki CZ, Sawicki J. Toxicity of inorganic compounds in the spirotox test: a miniaturized version of the spirostomum ambiguum test. Arch Environ Contam Toxicol 1998;34:1–5.
31. Na?cz Jawecki G, Sawicki J. A comparison of sensitivity of spirotox biotest with standard toxicity tests. Arch Environ Contam Toxicol 2002;42:389–95.
32. Michel D. Simply conceiving the arrhenius law and absolute kinetic constants using the geometric distribution? phys. A Stat Mech Appl 2013;329:4258-64.
33. Peleg M, Normand MD, Corradini MG. The arrhenius equation revisited. Crit Rev Food Sci Nutr 2012;52:830-51.
34. Suhane S, Nerkar AG, Modi K, Sawant SD. 2D and 3D-qsar analysis of amino (3-((3, 5-difluoro-4-methyl-6-phenoxypyridine-2-yl) oxy) phenyl) methaniminium derivatives as factor xa inhibitor. Int J Pharm Pharm Sci 2019;2:104-11.
35. Dastmalchia S, Hamzeh Mivehrouda M, Asadpour Zeynalic K. Comparison of different 2D and 3D-QSAR methods on activity prediction of histamine H3 receptor antagonists. Iran J Pharm Res 2012;11:97-108.
36. Koldina AM, Uspenskaya EV, Borodin AA, Pleteneva TV, Syroeshkin AV. Light scattering in research and quality control of deuterium depleted water for pharmaceutical application. Int J Appl Pharm 2019;11:271-8.
37. Syroeshkin A, Uspenskaya E, Pleteneva T, Morozova M, Maksimova T, Koldina A, et al. Mechanochemical activation of pharmaceutical substances as a factor for modification of their physical, chemical and biological properties. Int J Appl Pharm 2019;11:118-23.
38. Kubicar L, Viliam V, Vlastimil B. Study of phase transitions by transient methods. Solid State Phenom 2008;138:3-28.
39. Quach NK, Yang WD, Chung ZJ, Tran HL. The influence of the activation temperature on the structural properties of the activated carbon xerogels and their electrochemical performance. Hindawi 2017;9:9-18.
40. Lewis WK, Gilliland ER, Bauer WC. Characteristics of fluidized particles. Ind Eng Chem 1949;41:1104-17.
41. Zhoua XR, Caoa Y, Zhanga Q, Tiana X, Dongb H, Chena L, et al. Self-assembly nanostructure controlled sustained release, activity and stability of peptide drugs. Int J Pharm 2017;528:723-31.
42. Thombare M, Chavan P, Banka S. Solid-liquid circulating fluidized bed: a way forward. Rev Chem Eng 2017;35:1-44.
43. Grollman A. The vapor pressures of aqueous solutions with special reference to the problem of the state of water in biological fluids. J Gen Physiol 1931;14:661-83.
44. Wang J, Shao Y, Yan X, Zhu J. Review of (gas)-liquid-solid circulating fluidized beds as biochemical and environmental reactors. Chem Eng J 2019;12:1385-92.
45. Foroughi Dahr M, Mostoufi N, Sotudeh Gharebagh R, Chaouki J. Particle coating in fluidized beds. reference modue in chemistry, Molecular Sciences and Chemical Engineering; 2017;2:122-6.
46. Levitskaya OV, Syroeshkin AV, Pleteneva TV. Arrhenius kinetics as a bioactivity assessment criterion for drug substances and excipients. Pharm Chem J 2016;49:779–81.
47. Buonanno F, Guella G, Strim C, Ortenzi C. Chemical defence by mono-prenyl hydroquinone in a freshwater ciliate, spirostomum ambiguum. Hydrobiologia 2012;680:1-11.
48. Goncharuk VV, Syroeshkin AV, Zlatskiy IA. Quasichemical description of the cell death kinetics of cellular biosensor Spirostomum ambigua for testing the biological activity of aqueous solutions. J Water Chem Technol 2017;39:97–102.
49. Mauer J, Peltomäki M, Poblete S, Gomppe G, Fedosov D. Static and dynamic light scattering by red blood cells: a numerical study. PLoS One 2017;12:176-9.
50. Wang D, Phan N, Isely C, Bruene L, Bratlie KM. Effect of surface modification and macrophage phenotype on particle internalization. Biomacromolecules 2014;15:4102-10.
51. Hines RM, Khumnark M, Macphail B, Hines DJ. Administration of micronized caffeine using a novel oral delivery film results in rapid absorption and electroencephalogram suppression. Front ?harmacol 2019;10:983-8.
52. Post ST, Woutersen S, Bakker HJ. Quantum interference in the vibrational relaxation of the O–H stretch overtone of liquid H2O. J Physical Chem 2016;120:3441-9.
53. Medvedev ES, Osherov VI. Radiationless transitions in polyatomic molecules. Springer Ser Chem Phys 1995;57:196-9.
54. Kubicar L, Vretenar V, Bohac V. Study of phase transitions by transient methods. Solid State Phenom 2008;10:138, 3-28.
55. Sonar G, Rawat S. Optimization of pantoprazole enteric pellets coating process by QBD: effect of coating process variables on the intermediate quality of the product and scale up. Int J Pharm Pharm Sci 2015;7:80-7.
56. Raji K, Muthukumar V. Quantitative structure-activity relationships analysis of the anticonvulsant activity of erythrinine. Asian J Pharm Clin Res 2016;9:125-9.
57. Deore S, Shahi SR, Dabir P. Nanoparticle: as targeted drug delivery system for depression. Int J Curr Pharm Res 2016;8:7-11.
This work is licensed under a Creative Commons Attribution 4.0 International License.